| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 2,40,168 | 2,24,950 | +6.8% |
| EBITDA | 13,686 | 10,986 | +24.6% |
| Profit before tax | 13,686 | 10,986 | +24.6% |
| Net profit | 13,584 | 10,957 | +24.0% |
| EPS | ₹10.74 | ₹17.32 | −38.0% |
| Tap a line for its trend | Q1 FY27Jun 2026 | Q4 FY26Mar 2026 | Q3 FY26Dec 2025 | Q2 FY26Sep 2025 | Q1 FY26Jun 2025 | Q4 FY25Mar 2025 |
|---|
| 2,40,168 | 2,79,198 | 2,36,094 | 2,41,536 | 2,24,950 | 2,43,693 | |
Expenses | ||||||
| 2,26,208 | 2,54,233 | 2,22,826 | 2,30,951 | 2,12,730 | 2,23,422 | |
| 13,686 | 23,457 | 12,880 | 10,202 | 10,986 | 19,046 | |
| 13,686 | 23,457 | 12,880 | 10,202 | 10,986 | 19,046 | |
Profit | ||||||
| 13,686 | 23,457 | 12,880 | 10,202 | 10,986 | 19,046 | |
| 1,626 | −9,069 | 1,982 | 1,422 | 1,616 | 3,422 | |
| 13,584 | 23,467 | 12,930 | 10,098 | 10,957 | 19,039 | |
Per share | ||||||
| ₹10.74 | ₹37.10 | ₹20.44 | ₹15.97 | ₹17.32 | ₹30.10 | |
Revenue detail — as filed | ||||||
| 2,557 | 2,466 | 2,262 | 2,066 | 1,801 | 1,775 | |
| 1,09,685 | 1,09,211 | 1,07,704 | 1,12,528 | 1,03,252 | 93,443 | |
Expense detail — as filed | ||||||
| 1,867 | 3,022 | 3,051 | 1,265 | 1,320 | 2,004 | |
| 93.5 | 297 | 142 | 172 | 74.5 | 218 | |
| 6,048 | 8,891 | 5,839 | 7,522 | 5,686 | 5,943 | |
| 5,062 | 7,741 | 6,040 | 5,806 | 4,977 | 7,736 | |
| 5,062 | 7,733 | 6,040 | 5,807 | 4,975 | 7,735 | |
| −1.8 | 75.2 | −246 | −250 | −362 | −415 | |
| −566 | −544 | −84.6 | −157 | −26.1 | −1,014 | |
| −0.1 | −0.1 | 0.1 | −0.5 | −0.4 | 1.3 | |
Profit build-up — alternate / pre-Ind-AS tags | ||||||
| 13,686 | 23,457 | 12,880 | 10,202 | 10,986 | 19,046 | |
| 102 | −10.5 | −50.7 | 103 | 28.7 | 7.1 | |
| 1,626 | −9,069 | 1,982 | 1,422 | 1,616 | 3,422 | |
| 102 | −10.5 | −50.7 | 103 | 28.7 | 7.1 | |
| 13,584 | 23,467 | 12,930 | 10,098 | 10,957 | 19,039 | |
| 13,584 | 23,467 | 12,930 | 10,098 | 10,957 | 19,039 | |
| 1,77,262 | 1,70,003 | 1,46,548 | 1,33,621 | 1,31,131 | 1,20,217 | |
Per share — as-filed variants | ||||||
| ₹10.74 | ₹37.10 | ₹20.44 | ₹15.97 | ₹17.32 | ₹30.10 | |
| ₹10.74 | ₹37.10 | ₹20.44 | ₹15.97 | ₹17.32 | ₹30.10 | |
Appropriations & transfers | ||||||
| 1,78,490 | 1,71,231 | 1,47,683 | 1,34,730 | 1,32,156 | 1,21,194 | |
Insurance — revenue account (Policyholders') | ||||||
| 1,27,796 | 1,65,361 | 1,26,177 | 1,27,087 | 1,19,754 | 1,48,222 | |
| 1,27,623 | 1,65,067 | 1,25,988 | 1,26,930 | 1,19,618 | 1,47,917 | |
| 9,257 | 13,009 | 10,648 | 10,884 | 7,566 | 11,103 | |
| 62,129 | 82,233 | 69,617 | 65,320 | 60,179 | 79,425 | |
| 56,409 | 70,119 | 45,911 | 50,882 | 52,008 | 57,694 | |
| 1,920 | 3,139 | 2,272 | 2,204 | 1,754 | 2,804 | |
| 3,007 | 4,165 | 3,578 | 3,398 | 3,098 | 4,665 | |
| 135 | 437 | 189 | 204 | 125 | 267 | |
| 13,605 | 20,699 | 15,643 | 15,308 | 12,558 | 16,526 | |
| 8,543 | 12,965 | 9,604 | 9,501 | 7,583 | 8,791 | |
| 518 | 530 | 20.9 | 70.6 | 540 | 52.1 | |
| 1,21,911 | 1,80,168 | 1,13,819 | 1,06,977 | 97,551 | 1,42,765 | |
| 89,633 | 62,904 | 91,688 | 1,07,569 | 1,01,349 | 62,052 | |
| 0.0 | 59,623 | 103 | 0.0 | 0.0 | 56,236 | |
| 928 | 4,470 | 1,874 | 1,138 | 875 | 547 | |
| 0.0 | −0.2 | 23.5 | 81.8 | 43.6 | 85.9 | |
| 13,960 | 24,964 | 13,269 | 10,585 | 12,220 | 20,271 | |
| 13,960 | 24,964 | 13,269 | 10,585 | 12,220 | 20,271 | |
| 1,751 | 2,772 | 1,596 | 1,131 | 1,483 | 1,856 | |
| 30.8 | 32.4 | 37.7 | 40.2 | 40.8 | 43.0 | |
Insurance — Shareholders' account | ||||||
| 2,609 | 2,515 | 2,311 | 2,114 | 1,846 | 1,818 | |
| 14,818 | 24,708 | 13,983 | 11,568 | 12,584 | 20,232 | |
| 1,132 | 1,251 | 1,103 | 1,367 | 1,598 | 1,186 | |
| 2.9 | 0.2 | −2.6 | −19.8 | −1.1 | −7.9 | |
| 12,209 | 22,193 | 11,672 | 9,454 | 10,738 | 18,414 | |
| 611 | 721 | 1,085 | 1,316 | 1,059 | 1,141 | |
| 12,209 | 22,193 | 11,672 | 9,454 | 10,738 | 18,414 | |
| 9.0 | −1.3 | 10.1 | 6.5 | 10.1 | 6.3 | |
| 6.2 | 6.9 | 6.7 | 6.5 | 6.1 | 6.9 | |
Insurance — result & transfers | ||||||
| 14,888 | 89,058 | 15,245 | 11,723 | 13,096 | 77,053 | |
| 2,248 | 4,199 | 1,773 | 1,218 | 1,477 | 1,648 | |
| 51.5 | 49.3 | 49.0 | 48.1 | 44.9 | 43.5 | |
| 611 | 721 | 629 | 860 | 603 | 684 | |
Insurance — fund NPAs | ||||||
| 0.0 | 0.0 | 0.0 | 0.0 | 56.5 | 56.5 | |
| ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.01 | ₹0.01 | |
| 35.8 | 35.8 | 35.8 | 114 | 114 | 114 | |
| ₹0.08 | ₹0.08 | ₹0.10 | ₹0.25 | ₹0.30 | ₹0.30 | |
| 0.0 | −0.0 | 0.0 | −0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 7,132 | 7,169 | 7,746 | 7,935 | 8,322 | 8,329 | |
| 4.9 | 4.3 | 4.2 | 3.9 | 3.6 | 5.5 | |
| ₹0.01 | ₹0.01 | ₹0.02 | ₹0.02 | ₹0.02 | ₹0.02 | |
| 0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | −0.0 | 0.0 | −0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
Insurance — IRDAI ratios (as filed, not percentages) | ||||||
| 2.42× | 2.35× | 2.19× | 2.13× | 2.17× | 2.11× | |
| ₹0.02 | ₹0.02 | ₹0.02 | ₹0.02 | ₹0.02 | ₹0.02 | |
| ₹0.91 | ₹0.91 | ₹0.96 | ₹0.89 | ₹0.94 | ₹0.87 | |
| ₹0.11 | ₹0.13 | ₹0.12 | ₹0.12 | ₹0.10 | ₹0.11 | |
| ₹0.70 | ₹0.68 | ₹0.69 | ₹0.68 | ₹0.71 | ₹0.69 | |
| ₹0.66 | ₹0.63 | ₹0.64 | ₹0.63 | ₹0.66 | ₹0.65 | |
| ₹0.63 | ₹0.62 | ₹0.61 | ₹0.61 | ₹0.64 | ₹0.60 | |
| ₹0.62 | ₹0.57 | ₹0.59 | ₹0.58 | ₹0.63 | ₹0.56 | |
| ₹0.61 | ₹0.54 | ₹0.55 | ₹0.55 | ₹0.58 | ₹0.59 | |
Regulatory disclosures — filed alongside, not part of the P&L | ||||||
| ₹11.00 | −₹2.00 | −₹21.00 | ₹23.00 | ₹2.00 | ₹1.00 | |
| ₹323.00 | ₹141.00 | ₹171.00 | ₹488.00 | ₹122.00 | ₹130.00 | |
| ₹312.00 | ₹143.00 | ₹192.00 | ₹465.00 | ₹120.00 | ₹129.00 | |
| 1.0% | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 3 Months Ending | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|
| Total Income | 2,43,692.7 | 2,24,950.2 | 2,41,536.4 | 2,36,094.3 | 2,79,197.8 | 2,40,167.8 | |
| Expenses | |||||||
| Total Expenses | 2,23,422.2 | 2,12,729.9 | 2,30,951.0 | 2,22,825.7 | 2,54,233.3 | 2,26,207.8 | |
| EBITDA | 19,045.7 | 10,985.8 | 10,201.7 | 12,879.7 | 23,456.7 | 13,686.4 | |
| EBIT | 19,045.7 | 10,985.8 | 10,201.7 | 12,879.7 | 23,456.7 | 13,686.4 | |
| Profit | |||||||
| Pretax Income | 19,045.7 | 10,985.8 | 10,201.7 | 12,879.7 | 23,456.7 | 13,686.4 | |
| + Current Tax | 3,422.0 | 1,616.3 | 1,421.9 | 1,982.1 | -9,068.7 | 1,626.0 | |
| Net Income | 19,038.7 | 10,957.1 | 10,098.5 | 12,930.4 | 23,467.2 | 13,584.3 | |
| Per Share | |||||||
| Basic EPS | 30.10 | 17.32 | 15.97 | 20.44 | 37.10 | 10.74 | |
| Revenue Detail — as filed | |||||||
| + Investment Income | 1,774.5 | 1,801.1 | 2,066.0 | 2,261.8 | 2,465.9 | 2,557.2 | |
| + Income from Investments (net) | 93,442.8 | 1,03,252.0 | 1,12,528.3 | 1,07,704.3 | 1,09,210.7 | 1,09,685.3 | |
| Expense Detail — as filed | |||||||
| + Administration Expenses | 2,003.7 | 1,319.6 | 1,264.8 | 3,051.3 | 3,021.6 | 1,867.1 | |
| + Advertisement & Publicity | 217.7 | 74.5 | 172.3 | 141.7 | 297.0 | 93.5 | |
| + Employee Remuneration & Welfare | 5,942.6 | 5,685.8 | 7,522.2 | 5,839.2 | 8,891.2 | 6,048.3 | |
| + Commission | 7,736.0 | 4,977.3 | 5,806.0 | 6,039.5 | 7,741.0 | 5,061.6 | |
| + Commission (net) | 7,735.5 | 4,975.3 | 5,807.4 | 6,039.5 | 7,733.4 | 5,061.6 | |
| + Provision — Diminution in Investments | -414.6 | -362.4 | -250.2 | -245.8 | 75.2 | -1.8 | |
| + Provision — Doubtful Debts & Write-offs | -1,014.1 | -26.1 | -156.7 | -84.6 | -544.0 | -565.7 | |
| + Provision — Doubtful Debts incl. Write-off | 1.3 | -0.4 | -0.5 | 0.1 | -0.1 | -0.1 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | |||||||
| Profit / (Loss) before Tax | 19,045.7 | 10,985.8 | 10,201.7 | 12,879.7 | 23,456.7 | 13,686.4 | |
| + Current Taxes | 7.1 | 28.7 | 103.2 | -50.7 | -10.5 | 102.1 | |
| + Provision for Tax | 3,422.0 | 1,616.3 | 1,421.9 | 1,982.1 | -9,068.7 | 1,626.0 | |
| + Provisions for Taxes | 7.1 | 28.7 | 103.2 | -50.7 | -10.5 | 102.1 | |
| PAT before Extraordinary Items | 19,038.7 | 10,957.1 | 10,098.5 | 12,930.4 | 23,467.2 | 13,584.3 | |
| PAT after Extraordinary Items | 19,038.7 | 10,957.1 | 10,098.5 | 12,930.4 | 23,467.2 | 13,584.3 | |
| Profit Carried to Balance Sheet | 1,20,216.5 | 1,31,130.6 | 1,33,620.8 | 1,46,547.9 | 1,70,003.1 | 1,77,262.1 | |
| Per Share — as-filed variants | |||||||
| Basic & Diluted EPS before Extraordinary (not annualised) | 30.10 | 17.32 | 15.97 | 20.44 | 37.10 | 10.74 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | 30.10 | 17.32 | 15.97 | 20.44 | 37.10 | 10.74 | |
| Appropriations & Transfers | |||||||
| Reserves & Surplus excl. Revaluation Reserve | 1,21,193.9 | 1,32,156.1 | 1,34,730.4 | 1,47,683.1 | 1,71,230.9 | 1,78,490.0 | |
| Insurance — Revenue Account (Policyholders') | |||||||
| + Gross Premium Income | 1,48,222.0 | 1,19,753.9 | 1,27,087.3 | 1,26,176.6 | 1,65,360.8 | 1,27,796.1 | |
| + Net Premium Income | 1,47,917.2 | 1,19,618.4 | 1,26,930.0 | 1,25,988.2 | 1,65,067.2 | 1,27,623.2 | |
| + First-year Premium | 11,103.0 | 7,566.0 | 10,884.5 | 10,648.5 | 13,009.0 | 9,257.5 | |
| + Renewal Premium | 79,425.0 | 60,179.4 | 65,320.5 | 69,617.4 | 82,233.2 | 62,129.3 | |
| + Single Premium | 57,694.1 | 52,008.5 | 50,882.3 | 45,910.8 | 70,118.6 | 56,409.4 | |
| + Commission — First-year Premium | 2,804.2 | 1,754.1 | 2,203.7 | 2,271.9 | 3,138.9 | 1,920.1 | |
| + Commission — Renewal Premium | 4,665.1 | 3,098.5 | 3,398.3 | 3,578.3 | 4,165.5 | 3,007.0 | |
| + Commission — Single Premium | 266.6 | 124.8 | 204.0 | 189.3 | 436.7 | 134.5 | |
| + Expenses of Management | 16,526.2 | 12,558.3 | 15,308.4 | 15,643.5 | 20,698.7 | 13,604.5 | |
| + Operating Expenses — Insurance Business | 8,790.7 | 7,583.0 | 9,501.0 | 9,603.9 | 12,965.3 | 8,543.0 | |
| + Expenses — Non-insurance | 52.1 | 539.9 | 70.6 | 20.9 | 530.0 | 517.8 | |
| + Benefits Paid (net) | 1,42,764.9 | 97,550.9 | 1,06,976.7 | 1,13,818.8 | 1,80,168.5 | 1,21,911.5 | |
| + Change in Actuarial Liability | 62,051.9 | 1,01,349.4 | 1,07,569.1 | 91,688.2 | 62,903.8 | 89,633.2 | |
| + Bonus Allocated to Policyholders | 56,235.9 | 0.0 | 0.0 | 102.9 | 59,622.7 | 0.0 | |
| + Interim Bonus Paid | 546.5 | 875.3 | 1,137.5 | 1,873.5 | 4,470.4 | 928.4 | |
| + GST on Linked Charges | 85.9 | 43.6 | 81.8 | 23.5 | -0.2 | 0.0 | |
| Surplus in the Revenue Account | 20,270.5 | 12,220.3 | 10,585.4 | 13,268.6 | 24,964.5 | 13,960.1 | |
| Net Surplus / (Deficit) | 20,270.5 | 12,220.3 | 10,585.4 | 13,268.6 | 24,964.5 | 13,960.1 | |
| + Funds for Future Appropriation | 1,856.4 | 1,482.8 | 1,131.1 | 1,596.1 | 2,771.7 | 1,750.9 | |
| + Policyholders' Liabilities to Shareholders' Fund | 43.0 | 40.8 | 40.2 | 37.7 | 32.4 | 30.8 | |
| Insurance — Shareholders' Account | |||||||
| + Income under Shareholders' Account | 1,818.0 | 1,846.0 | 2,114.1 | 2,310.7 | 2,515.2 | 2,608.8 | |
| + Shareholders' Account Income | 20,232.2 | 12,583.5 | 11,568.5 | 13,983.2 | 24,708.0 | 14,818.0 | |
| + Shareholders' Account Expenses | 1,186.4 | 1,597.8 | 1,366.8 | 1,103.5 | 1,251.3 | 1,131.6 | |
| + Shareholders' Provision — Diminution in Investments | -7.9 | -1.1 | -19.8 | -2.6 | 0.2 | 2.9 | |
| + Transfer from Policyholders' Account | 18,414.1 | 10,737.5 | 9,454.3 | 11,672.5 | 22,192.8 | 12,209.2 | |
| + Transfer of Funds to Policyholders' Account | 1,140.8 | 1,059.4 | 1,316.5 | 1,085.0 | 721.2 | 610.9 | |
| + Transferred to Shareholders' Account | 18,414.1 | 10,737.5 | 9,454.3 | 11,672.5 | 22,192.8 | 12,209.2 | |
| Shareholders' Fund — with Unrealised Gains | 6.3 | 10.1 | 6.5 | 10.1 | -1.3 | 9.0 | |
| Shareholders' Fund — without Unrealised Gains | 6.9 | 6.1 | 6.5 | 6.7 | 6.9 | 6.2 | |
| Insurance — Result & Transfers | |||||||
| Surplus / (Deficit) | 77,053.0 | 13,095.6 | 11,722.9 | 15,244.9 | 89,057.5 | 14,888.5 | |
| + Other Income — Policyholders' Account | 1,648.4 | 1,476.9 | 1,218.0 | 1,773.2 | 4,198.7 | 2,248.5 | |
| + Other Income — Shareholders' Account | 43.5 | 44.9 | 48.1 | 49.0 | 49.3 | 51.5 | |
| + Transfer of Funds from Shareholders' Account | 684.4 | 602.9 | 860.1 | 628.6 | 721.2 | 610.9 | |
| Insurance — Fund NPAs | |||||||
| + Gross NPAs — Shareholders' Fund | 56.5 | 56.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Gross NPA % — Shareholders' Fund | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |
| + Gross NPAs — Linked Non-participating | 114.2 | 114.2 | 114.2 | 35.8 | 35.8 | 35.8 | |
| + Gross NPA % — Linked Non-participating | 0.30 | 0.30 | 0.25 | 0.10 | 0.08 | 0.08 | |
| + Linked Non-participating — with Unrealised Gains | 0.0 | 0.0 | -0.0 | 0.0 | -0.0 | 0.0 | |
| + Linked Non-participating — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Gross NPAs — Non-linked Participating | 8,328.7 | 8,322.2 | 7,934.8 | 7,745.7 | 7,169.4 | 7,132.2 | |
| + Net NPAs — Non-linked Participating | 5.5 | 3.6 | 3.9 | 4.2 | 4.3 | 4.9 | |
| + Gross NPA % — Non-linked Participating | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
| + Non-linked Participating — with Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | -0.0 | 0.0 | |
| + Non-linked Participating — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Non-linked Non-participating — with Unrealised Gains | 0.0 | 0.0 | -0.0 | 0.0 | -0.0 | 0.0 | |
| + Non-linked Non-participating — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | |||||||
| Solvency Ratio (x, one scale) | 2.11 | 2.17 | 2.13 | 2.19 | 2.35 | 2.42 | |
| Solvency Ratio (as filed) | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Conservation Ratio | 0.87 | 0.94 | 0.89 | 0.96 | 0.91 | 0.91 | |
| Expenses of Management Ratio | 0.11 | 0.10 | 0.12 | 0.12 | 0.13 | 0.11 | |
| Persistency — 13th Month | 0.69 | 0.71 | 0.68 | 0.69 | 0.68 | 0.70 | |
| Persistency — 25th Month | 0.65 | 0.66 | 0.63 | 0.64 | 0.63 | 0.66 | |
| Persistency — 37th Month | 0.60 | 0.64 | 0.61 | 0.61 | 0.62 | 0.63 | |
| Persistency — 49th Month | 0.56 | 0.63 | 0.58 | 0.59 | 0.57 | 0.62 | |
| Persistency — 61st Month | 0.59 | 0.58 | 0.55 | 0.55 | 0.54 | 0.61 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||
| Investor Complaints — During the Period | 1.00 | 2.00 | 23.00 | -21.00 | -2.00 | 11.00 | |
| Investor Complaints — Received | 130.00 | 122.00 | 488.00 | 171.00 | 141.00 | 323.00 | |
| Investor Complaints — Disposed | 129.00 | 120.00 | 465.00 | 192.00 | 143.00 | 312.00 | |
| Government of India Shareholding % | 0.97 | 0.97 | 0.97 | 0.97 | 0.97 | 0.97 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||
| Other Operating Expenses | 626.7 | 503.0 | 541.7 | 571.8 | 755.5 | 534.1 | |
Life Insurance Corporation of India (NSE: LICI) will announce its Q2 FY27 results (July–September 2026) on Thursday, 5 November 2026, according to the board-meeting notice it filed on 14 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹13,584 crore, up 24.0% from ₹10,957 crore in Q1 FY26 and down 42.1% from ₹23,467 crore in Q4 FY26.
On 5 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 14 October 2026). Last year it reported Q2 FY26 on 6 November 2025.
With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹10,098 crore. The latest quarter, Q1 FY27, had a net profit of ₹13,584 crore.
Consolidated net profit was ₹13,584 crore, up 24.0% from ₹10,957 crore in Q1 FY26 and down 42.1% from ₹23,467 crore in Q4 FY26.
Net profit by quarter: ₹10,098 crore in Q2 FY26, ₹12,930 crore in Q3 FY26, ₹23,467 crore in Q4 FY26 and ₹13,584 crore in Q1 FY27. That is ₹60,080 crore over the four quarters.
Consolidated net profit was ₹57,453 crore in FY26 (April 2025–March 2026), up 18.9% from ₹48,320 crore in FY25.
From Life Insurance Corporation of India's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.
Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.